Related Experiment Videos

Perinatal changes in serum mannose-binding protein (MBP) levels

I Terai1, K Kobayashi

  • 1Department of Laboratory Medicine, Hokkaido University School of Medicine, Sapporo, Japan.

Immunology Letters
|November 1, 1993
PubMed

Insights

Newborns have significant mannose-binding protein (MBP) at birth, which increases substantially within five days. This suggests MBP production is triggered by the infant's new environment.

Area of Science:

  • Immunology
  • Neonatal physiology

Background:

  • Mannose-binding protein (MBP) is a key component of the innate immune system.
  • Understanding MBP levels in newborns is crucial for assessing immune readiness.

Purpose of the Study:

  • To analyze serum mannose-binding protein (MBP) levels in normal newborns from birth up to five days.
  • To investigate the dynamic changes and potential triggers for MBP production in neonates.

Main Methods:

  • Serum samples were collected from normal newborn infants on day 0 (at birth) and through day 5 post-birth.
  • Quantification of mannose-binding protein (MBP) levels was performed using established laboratory assays.

Main Results:

  • Significant levels of mannose-binding protein (MBP), approximately 1 microgram/ml, were detected at birth.
  • MBP serum concentrations showed a marked increase starting from day 2, reaching peak levels of about 2.5 micrograms/ml by day 5.
  • The observed rapid increase indicates a robust production of MBP in the early neonatal period.

Conclusions:

  • Newborn infants possess substantial mannose-binding protein (MBP) levels at birth.
  • MBP levels significantly elevate within the first five days of life, suggesting rapid induction.
  • These findings imply that environmental changes experienced by the infant after birth stimulate MBP production.

Related Concept Videos